计算机药物重定位,驱动基因和治疗肺腺癌的治疗方法的进步
Sajjad Nematzadeh1, Arzu Karaul1
1Software Engineering, Engineering and Natural Sciences, Istanbul Topkapi University, Istanbul 34087, Türkiye.
Biomolecules
|October 29, 2025
概括
本综述通过检查驱动基因和计算方法来探索肺腺癌 (LUAD) 的药物重定位. 它综合了最近的研究,突出了LUAD的治疗途径,并将计算方法集成到翻译研究中.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺腺癌 (LUAD) 是癌症死亡的主要原因.
- 识别驱动基因和治疗点对于LUAD治疗至关重要.
- 药物重定向提供了一个有希望的策略,以加速LUAD治疗的发展.
研究的目的:
- 为了对LUAD驱动基因及其在疾病中的作用进行分类.
- 审查实验和计算药物重定向方法.
- 综合最近的LUAD计算重定向研究,用于翻译研究.
主要方法:
- 编目候选LUAD驱动基因及其功能.
- 审查六个实验和八个计算药物重定向方法家族.
- 使用计算镜头评估LUAD重新定位研究.
主要成果:
- 一个精心策划的LUAD驱动基因面板,映射到路径,改变,功能和治疗影响.
- 药物重定向方法的概述,包括实验和计算方法.
- 最近LUAD计算重定向研究的综合,详细说明方法,候选药物和数据集.
结论:
- 计算方法显著补充了在LUAD药物发现中的实验方法.
- 将计算药物重定向集成到翻译研究中可以加速LUAD治疗开发.
- 本综述提供了一个利用计算工具的框架,以确定新的LUAD治疗策略.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


